Brooklyn Immunotherapeutics Inc (BTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BTX | AMGN | GILD | CELG | BIIB |
| Company | Brooklyn Immunotherapeutics Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.9760 | 265.72 | 65.50 | 108.01 | 201.22 |
| High | 4.2000 | 271.68 | 66.35 | 108.59 | 209.64 |
| Low | 3.6200 | 265.72 | 64.63 | 107.27 | 199.10 |
| Last | 4.1020 | 271.24 | 65.72 | 108.24 | 209.27 |
| Change | +0.0020 | +1.86 | +0.45 | +0.11 | +6.81 |
| % Change | +0.05% | +0.69% | +0.69% | +0.10% | +3.36% |
| Volume | 127,880 | 865,616 | 7,699,888 | 191,230,496 | 1,065,880 |
| 20-Day Average Volume | 607,865 | 2,072,988 | 6,814,843 | 16,188,930 | 1,234,985 |
| Previous Close | 4.1000 | 269.38 | 65.27 | 108.13 | 202.46 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2396 | 270.03 | 68.30 | 108.17 | 201.14 |
| 20-Day Raw Stochastic | 20.71% | 43.56% | 11.55% | 63.25% | 75.31% |
| 20-Day Relative Strength | 28.92% | 46.35% | 30.39% | 64.69% | 50.05% |
| Weighted Alpha | -97.70 | +9.91 | -23.16 | +46.30 | -31.50 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 100% Sell | 72% Sell | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Sell | 100% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.25% since 10/07/22 | +0.70% since 04/19/24 | -1.70% since 04/19/24 | -1.97% since 11/13/19 | +7.63% since 04/19/24 |
| Low | 0.1699 on 10/13/22 | 265.72 on 04/26/24 | 64.63 on 04/26/24 | 107.27 on 11/20/19 | 192.75 on 04/23/24 |
| High | 0.2430 on 10/10/22 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 110.53 on 11/14/19 | 209.64 on 04/26/24 |
| 1-Month | |||||
| %Chg | -43.00% since 09/14/22 | -3.89% since 03/26/24 | -9.37% since 03/26/24 | +5.14% since 10/18/19 | -1.33% since 03/26/24 |
| Low | 0.1699 on 10/13/22 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 102.40 on 10/21/19 | 189.44 on 04/19/24 |
| High | 0.3863 on 09/15/22 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 217.57 on 03/28/24 |
| 3-Month | |||||
| %Chg | -65.92% since 07/14/22 | -13.14% since 01/26/24 | -17.48% since 01/26/24 | +13.63% since 08/20/19 | -14.55% since 01/26/24 |
| Low | 0.1699 on 10/13/22 | 260.68 on 04/19/24 | 64.63 on 04/26/24 | 93.41 on 08/23/19 | 189.44 on 04/19/24 |
| High | 0.6400 on 07/18/22 | 329.72 on 02/05/24 | 80.00 on 01/29/24 | 110.70 on 11/13/19 | 251.99 on 01/31/24 |
| 6-Month | |||||
| %Chg | -87.49% since 04/14/22 | +0.40% since 10/26/23 | -16.40% since 10/26/23 | +14.14% since 05/20/19 | -13.22% since 10/26/23 |
| Low | 0.1699 on 10/13/22 | 249.70 on 10/31/23 | 64.63 on 04/26/24 | 89.08 on 07/23/19 | 189.44 on 04/19/24 |
| High | 1.6700 on 04/18/22 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 12,059 | 144,488,960 | 81,266,176 | 77,035,920 | 29,429,788 |
| Shares Outstanding, K | 58,826 | 536,376 | 1,245,077 | 711,714 | 145,361 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,835,600,000 |
| Annual Net Income | -122,310,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,386,300,000 |
| Last Quarter Net Income | -3,398,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 249,700,000 |
| 60-Month Beta | 4.61 | 0.58 | 0.19 | 1.41 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.17 on 07/01/22 | 4.71 on 02/06/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 3.67 on 04/24/24 |
| Latest Earnings Date | 11/08/22 | 05/02/24 | 04/25/24 | 10/31/19 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.64 | 9.98 | 10.99 | 13.47 |